EUVIMEDEUVIMED entdecken
Crossref

Relationship between IL-22 and IL-22BP in diabetic cognitive dysfunction

Xiaobai Wang, Shengxue Yu, Wenqiang Liu, Pan Lv, Lipan Zhao, Yufei Wang, Cong Fu, Lu Meng, Qi Yang, Xuehua Wang, Ying Huang, Zhongfu Zuo und 1 weitere

Acta Diabetologica · 30.01.2023 · 60 (5) · 631-644

DOI: 10.1007/s00592-022-02024-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Diabetologica, online erschienen am 30.01.2023. Verfasst von Xiaobai Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning Key Laboratory of Diabetic Cognitive and Perceptive Dysfunction, Jinzhou Medical University, Jinzhou, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Postdoctoral Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: CD4 + T helper (Th)22 cells play a regulatory role in autoimmune diseases such as type 1 diabetes mellitus. The Th22-related cytokine interleukin (IL)-22, the expression of which is increased in diabetes mellitus (DM), can act as a neurotrophic factor to protect neurons from apoptosis. Paradoxically, neuronal apoptosis and learning and memory decline occur in DM. In this study, we investigated the relationship between IL-22 and its receptors IL-22Rα1 and IL-22 binding protein (IL-22BP, a soluble inhibitor of IL-22) in diabetic encephalopathy (DE) and the effects of IL-22 on hippocampal neurons, learning and memory. METHODS: A C57BL/6 mouse model of diabetes was constructed by intraperitoneal injection of streptozotocin. The mice were randomly divided into 4 groups: the control group, diabetes group, diabetes + recombinantIL-22 (rIL-22) group and diabetes + IL-22BP group. The Morris water maze test was used to evaluate learning and memory, the expression of IL-22 was measured by ELISA, and Evans Blue staining was used to evaluate blood-brain barrier permeability. Quantitative reverse transcription polymerase chain reaction (RT-qPCR) was used to measure the mRNA expression of IL-22 and IL-22Rα1 in the hippocampus. The morphology and number of hippocampal neurons were assessed by Nissl staining, and TUNEL staining was used to detect hippocampal neuronal apoptosis. Immunofluorescence was used to analyze IL-22Rα1 expression and localization in hippocampus, and Western blotting was used to evaluate the expression of IL-22, IL-22Rα1, IL-22BP, and the apoptosis related proteins Caspase-3 and C-caspase-3. RESULTS: Compared with those in the control group, mice in the diabetes group showed cognitive decline; apoptosis of hippocampal neurons; increased expression of hippocampal Caspase-3, C-Caspase-3, IL-22, IL-22Rα1, and IL-22BP; and a decreased IL-22/IL-22BP ratio. Learning and memory were improved, neuronal apoptosis was attenuated, IL-22Rα1 expression and the IL-22/IL-22BP ratio were increased, and caspase-3 and C-caspase-3 expression was decreased in the rIL-22-treated group compared with the diabetes group. IL-22BP treatment aggravated diabetic cognitive dysfunction and pathological alterations in the hippocampus, decreased the IL-22/IL-22BP ratio, and increased the expression of caspase-3 and C-caspase-3 in mice with diabetes. CONCLUSION: A decrease in the IL-22/IL-22BP ratio plays an important role in diabetic cognitive dysfunction, and rIL-22 can effectively alleviate DE. Herein, we shed light on the interaction between IL-22 and IL-22BP as therapeutic targets for DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionDiabetes Mellitus, ExperimentalRatsMice, Inbred C57BLCaspase 3ApoptosisBrain DiseasesHypoglycemiaInterleukin-22InterleukinsRats, Sprague-DawleyMiceAnimals

Stichwörter der Autor:innen

ApoptosisDiabetes mellitusIL-22IL-22BP

Substanzen

Caspase 3Interleukin-22Interleukins

Autor:innen und Institutionen

  • Liaoning Key Laboratory of Diabetic Cognitive and Perceptive Dysfunction, Jinzhou Medical University, Jinzhou, China.
  • Department of Anatomy, Histology and Embryology, Jinzhou Medical University, Jinzhou, China.
  • Liaoning Key Laboratory of Diabetic Cognitive and Perceptive Dysfunction, Jinzhou Medical University, Jinzhou, China. zuozhongfu@jzmu.edu.cn.
  • Department of Anatomy, Histology and Embryology, Jinzhou Medical University, Jinzhou, China. zuozhongfu@jzmu.edu.cn.
  • Department of Anatomy, Histology and Embryology, Postdoctoral Research Station, Guangxi Medical University, Nanning, China. zuozhongfu@jzmu.edu.cn.
  • Liaoning Key Laboratory of Diabetic Cognitive and Perceptive Dysfunction, Jinzhou Medical University, Jinzhou, China. liuxuezheng@jzmu.edu.cn.

Förderung

  • Postdoctoral Science Foundation of Jiangsu Province

Zitieren

APA

Wang, X., Yu, S., Liu, W., Lv, P., Zhao, L., Wang, Y., Fu, C., Meng, L., Yang, Q., Wang, X., Huang, Y., Zuo, Z., & Liu, X. (2023). Relationship between IL-22 and IL-22BP in diabetic cognitive dysfunction. Acta Diabetologica, 60(5), 631-644. https://doi.org/10.1007/s00592-022-02024-5

Vancouver

Wang X, Yu S, Liu W, Lv P, Zhao L, Wang Y, et al. Relationship between IL-22 and IL-22BP in diabetic cognitive dysfunction. Acta Diabetologica. 2023;60(5):631-644. doi:10.1007/s00592-022-02024-5

BibTeX
@article{Wang2023,
  author = {Wang, Xiaobai and Yu, Shengxue and Liu, Wenqiang and Lv, Pan and Zhao, Lipan and Wang, Yufei and Fu, Cong and Meng, Lu and Yang, Qi and Wang, Xuehua and Huang, Ying and Zuo, Zhongfu and Liu, Xuezheng},
  title = {Relationship between IL-22 and IL-22BP in diabetic cognitive dysfunction},
  journal = {Acta Diabetologica},
  year = {2023},
  volume = {60},
  number = {5},
  pages = {631--644},
  doi = {10.1007/s00592-022-02024-5}
}
Kostenlos starten →